MONDAY, April 29, 2024 (HealthDay News) — Britain’s King Charles III is back to resuming his royal duties following treatment for cancer, Buckingham Palace announced Friday. “His Majesty The King will shortly return to public-facing duties after a period of treatment and recuperation following his recent cancer diagnosis,” the PalaceContinue Reading

THURSDAY, April 25, 2024 (HealthDay News) — As many patients already know, urinary tract infections (UTIs) can recur despite the use of antibiotics. So, it’s welcome news that the U.S. Food and Drug Administration on Wednesday approved Pivya (pivmecillinam) to fight bacterial UTIs. “UTIs are a very common condition impactingContinue Reading

MONDAY, March 11, 2024 (HealthDay News) — A cancer drug duo more than doubled the survival of people battling the most common form of advanced bladder cancer, trial results show. Patients who took a combo of meds called EV+P — enfortumab vedotin and pembrolizumab (Keytruda) — had an average 31.5Continue Reading